Mitral Regurgitation - Valvular Heart Disease Guidelines

Valvular Heart Disease

ACC/AHA Valvular Heart Disease - Mitral Regurgitation GUIDELINES Apps brought to you charge courtesy of Guideline Central and Abbott Vascular.

Issue link: https://eguideline.guidelinecentral.com/i/362036

Contents of this Issue

Navigation

Page 47 of 59

46 Infectious Endocarditis Table 31B. Diagnosis and Treatment of IE (cont'd) Recommendations COR LOE Surgical erapy Decisions about timing of surgical intervention should be made by a multispecialty Heart Valve Team of cardiolog y, cardiothoracic surgery, and infectious disease specialists. I B Early surgery a is indicated in patients with IE who present with valve dysfunction resulting in symptoms of HF. I B Early surgery a is indicated in patients with le-sided IE caused by S. aureus, fungal, or other highly resistant organisms. I B Early surgery a is indicated in patients with IE complicated by heart block, annular or aortic abscess, or destructive penetrating lesions. I B Early surgery a for IE is indicated in patients with evidence of persistent infection as manifested by persistent bacteremia or fevers lasting longer than 5-7 days aer onset of appropriate antimicrobial therapy. I B Surgery is recommended for patients with PVE and relapsing infection (defined as recurrence of bacteremia aer a complete course of appropriate antibiotics and subsequently negative blood cultures) without other identifiable source for portal of infection. I C Complete removal of pacemaker or defibrillator systems, including all leads and the generator, is indicated as part of the early management plan in patients with IE with documented infection of the device or leads. I B Complete removal of pacemaker or defibrillator systems, including all leads and the generator, is reasonable in patients with valvular IE caused by S. aureus or fungi, even without evidence of device or lead infection. IIa B Complete removal of pacemaker or defibrillator systems, including all leads and the generator, is reasonable in patients undergoing valve surgery for valvular IE. IIa C Early surgery a is reasonable in patients with IE who present with recurrent emboli and persistent vegetations despite appropriate antibiotic therapy. IIa B Early surgery a may be considered in patients with NVE who exhibit mobile vegetations >10 mm in length (with or without clinical evidence of embolic phenomena). IIb B a Early surgery is defined as during initial hospitalization before completion of a full therapeutic course of antibiotics.

Articles in this issue

view archives of Mitral Regurgitation - Valvular Heart Disease Guidelines - Valvular Heart Disease